Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements Limited has announced a shareholder meeting scheduled for December 30, 2025 to approve a Scheme of Arrangement with Penna Cement Industries Limited under National Company Law Tribunal orders dated October 31 and November 19, 2025. The meeting will be held virtually via video conferencing, with remote e-voting open from December 26–29, 2025. Approval requires a three-fourths majority by value of equity shareholders, plus majority support from public shareholders specifically. The scheme remains subject to tribunal and regulatory approvals post-vote.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 27 November 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 27 November 2025

HDFCBANK HDFC Bank Limited Corporate Action TITAN Titan Company Limited Buyback / Redemption ULTRACEMCO UltraTech Cement Limited Board Meeting ULTRACEMCO UltraTech Cement Limited Board Meeting HINDUNILVR Hindustan Unilever Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.